Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.

Saved in:

Bibliographic Details
Title:	Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.
Authors:	Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Koo JY; UCSF Psoriasis and Skin Treatment Center, San Francisco, CA, USA., Jaworski J; Centrum Medyczne Reuma Park, Warsaw, Poland., Trefler J; Reuma Centrum, Warsaw, Poland., Daniluk S; ClinicMed Daniluk, Nowak Sp.K, Białystok, Poland., Dudek A; Centrum Medyczne AMED, Warsaw, Poland., Baran W; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland., Owczarek W; Royalderm/Department of Dermatology, Military Institute of Medicine-National Research Institute, Warsaw, Poland., Kolinek J; Medycyna Kliniczna, Warsaw, Poland., Brzewski P; Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Krakow, Poland., Sikora M; National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland., Krogulec M; Rheumatology Clinic NZOZ Lecznica MAK-MED, Nadarzyn, Poland., Kim S; Celltrion, Inc., Incheon, Republic of Korea., Bae Y; Celltrion, Inc., Incheon, Republic of Korea., Jeon D; Celltrion, Inc., Incheon, Republic of Korea., Choi E; Celltrion, Inc., Incheon, Republic of Korea., Cha J; Celltrion, Inc., Incheon, Republic of Korea., Lee H; Celltrion, Inc., Incheon, Republic of Korea., Choi S; Celltrion, Inc., Incheon, Republic of Korea., Pariser DM; Eastern Virginia Medical School and Virginia Clinical Research, Inc., 6160 Kempsville Circle, Suite 200A, Norfolk, VA, 23502, USA. dpariser@pariserderm.com.
Source:	Advances in therapy [Adv Ther] 2025 Mar; Vol. 42 (3), pp. 1582-1599. Date of Electronic Publication: 2025 Feb 11.
Publication Type:	Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info:	Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1865-8652
DOI:	10.1007/s12325-024-03100-8